Surveillance for infections and other adverse events in dialysis patients in southern Gran Canaria;Vigilancia de infecciones y otros eventos adversos en pacientes en diálisis en el área sur de Gran Canaria

Nefrologia

Volumn 31, Issue 4, 2011, Pages 457-463

  Quori, A ^a   Baamonde Laborda, E ^b   Garcia Canton C ^a   Lago Alonso, M M ^a   Toledo Gonzalez A ^a   Monzon Jimenez E ^a   Jimenez Diaz D ^b   de Andrés, M Checa ^a   Molina Cabrillana, J ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b Centro de Hemodiálisis Avericum   (Spain)

Author keywords

Dialysis; Nosocomial infection; Patient safety; Surveillance; Vascular access

Indexed keywords

ANTIINFECTIVE AGENT;

ARTERIOVENOUS SHUNT; ARTICLE; ATLANTIC ISLANDS; BACTEREMIA; CATHETER INFECTION; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CROSS INFECTION; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEALTH SURVEY; HUMAN; INCIDENCE; INDWELLING CATHETER; MICROBIOLOGY; MULTICENTER STUDY; MULTIDRUG RESISTANCE; PERITONEAL DIALYSIS; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK MANAGEMENT; SPAIN; THROMBOSIS;

ANTI-BACTERIAL AGENTS; ARTERIOVENOUS SHUNT, SURGICAL; ATLANTIC ISLANDS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK MANAGEMENT; SPAIN; THROMBOSIS;

EID: 79961125651     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Apr.10605     Document Type: Article

References (30)

1. To Err Is Human Institute of Medicine. Washington DC: Library of The Congress, 2000;1-5.
2. Tokars J, Millar E, Stein G. New national surveillance system for hemodialysis-associated infections: initial results. Am J Infect Control 2002;30(5):288-95.
3. Klevens RM, Edwards JR. Dialysis Surveillance Report: National Healthcare Safety Network (NHSN) Summary 2006. Semin Dial 2008;21(1):24-8.
4. Klevens RM, Tokars JJ, Andrus M. Electronic reporting of infections associated with hemodialysis Nephrology News & Issues June 2005 37-43. Disponible en: http://www.cdc.gov/nhsn/PDFs/dataStat/2006_DialysisSurvReport.pdf. Accedido 02/08/2010.
5. Ravani P, Spergel LM, Asif A, Roy-Chaudhury P, Besarab A. Clinical epidemiology of arteriovenous fistula in 2007. J Nephrol 2007;20:141-9.
6. Hoggard J, Saad T, Schon D, Vesely TM, Royer T. Guidelines for venous access in patients with chronic kidney disease. Semin Dial 2008;21(2):186-91.
7. Rayner HC, Besarab A, Brown WW, Disney A, Salto A, Pisoni RL. Vascular access results from the Dialysis Outcome and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines. Am J Kidney Dis 2004;44(Suppl2):S22-S26.
8. Ethier J, Mendelssohn DC, Elder S, Hasegawa T, Akizwa T, Akiba T, et al. Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study. Nephrol Dial Transplant 2008;23:3219-26.
9. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among haemodialysis patients. Kidney Int 2002;62:620-6.
10. Hajaar J, Marc R. Surveillance des infections chez les hemodialysés croniques. Néphrologie 2004;25:133-40.
11. U.S. Department oh Health & Human Services, Center for Medicare & Medicaid Services. Fistula First Breakthrough (Website). Disponible en: http://fistulafirst.org. Accedido Septiembre 2007.
12. Allon M, Robbin ML. Increasing arteriovenous fistulas in haemodialysis patients: problems and solutions. Kidney Int 2002;62:1109-24.
13. Bailey JL, Balter P, Berns J, Butera E, Depner T, Douglas C, et al. Recommendation for preventing transmission of infections among chronic hemodialysis patients. MMWR Recommendation and Reportsl 2001;50(RR05):1-43. Disponible en: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5005a1.htm.
14. Collins A, Forrest B, Klevens RM, Patel DDS, Arduino MJ, Fosheim G, et al. Invasive Methicillin-resistant Staphylococcus aureus infections among dialysis patient. MMWR Recommendation and Reports 2007;59(RR09):197-9. Disponible en: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5609a3.htm.
15. McDonald LC, Hageman JC. Vancomycin-intermediate and resistant Staphylococcus aureus: What the nephrologist needs to know. Nephrol News Issues 2004;18(12):63-75.
16. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital epidemiology and infection control (3rd ed.). Philadelphia: Lippincott Williams & Wilkins, 2004; 1659-1702.
17. Gaynes R, Richards C, Edwards J, Emori T, Horan T, Echanove JA, et al. Feeding back surveillance data to prevent hospital-acquired infections. Emerg Infect Dis 2001;7:295-8.
18. Guidance on infection control in healthcare settings in Europe. Recommended practices, standards and indicators for healthcare associate infections and antibiotic resistance. Disponible en: http://helics.univ-lyon1.fr/StandardsandIndicators.htm.
19. NICE Final Guidelines. Prevention oh healthcare-associated infections in primary and community care. June 2003. Disponible en: http://www.nice.org.uk/nicemedia/pdf/Infection_control_fullguideline.pdf.
20. Tordoir JH, Mickley V. European guidelines for vascular access: clinical algorithms on vascular access for hemodialysis. EDTNA ERCA 2003;29:131-6.
21. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association. Section I. Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transplant 2002;17(Suppl 7):7-15.
22. Sociedad Española de Nefrología. Guía de acceso vascular. Noviembre, 2004. Disponible en: http://www.senefro.org/modules/subsection/files/guia_acceso_vascular.pdf?check_idfile=984.
23. Sociedad Española de Medicina Preventiva, Salud Pública e Higiene. Documento de consenso sobre recomendaciones y recursos necesarios para un programa de control de la infección nosocomial en los hospitales españoles. Disponible en: http://www.mpsp.org/mpsp/index.html.
24. Rodríguez Hernandez J, López Pedret J, Piera L. El acceso vascular en España: análisis de su distribución, morbilidad y sistemas de monitorización. Nefrologia 2001;21(1):45-51.
25. Edwards J, Mstat K, Peterson BBA, Yi Mu P, Shailendra Ph, Allen-Bridson K, et al. National Healthcare safety Network (NHSN) report. Data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37:783-805.
26. Rehman R, Schmidt RJ, Moss AH. Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol 2009;4:456-60.
27. Konner K. A primer on the AV fistula-Achille's heel, but also «Cinderella» of hemodialysis. J Am Soc Nephrol 1999;14:2094-8.
28. Kevan R, McDonald S. Vascular access and all-cause mortality; a propensity score analysis. J Am Soc Nephrol 2004;15:477-86.
29. Ferrero S, Saltarelli M, Quori A, Campobasso M, Argentero P. Dialysis surveillance monitoring bloodstream and vascular infections. G Ital Nefrol 2008;25:347-53.
30. George A, Tokars JL, Clutterbuck EJ, Bamford KB, Pusey C, Holmes AH. Reducing dialysis associated bacteraemia, and recommendations for surveillance in the UK: prospective study. BMJ 2006;332:1435-9.